Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
January Dow Dogs: 1 'Safer' Buy, And 5 With Promise
12:21pm, Thursday, 02'nd Jan 2025
Verizon Communications is the only Dow Dog meeting the ideal of annual dividends from $1K invested, exceeding the single share price. Analysts forecast 11.36% to 31.73% net gains from the top ten Dow
5 Large Drug Stocks to Keep An Eye On in the New Year
10:02am, Thursday, 02'nd Jan 2025
R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), AbbVie (ABBV), AstraZeneca (AZN) and Pfizer (PFE) are worth retain
2 Dividend Kings to Rule Them All in 2025
09:15am, Thursday, 02'nd Jan 2025
If history is any teacher, the best thing you can do with your money is buy dividend stocks.
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
08:00am, Thursday, 02'nd Jan 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2025 of $1.24 per share on the com
3 Of The Most Consistent Dividend Stocks For Retirees
08:00am, Thursday, 02'nd Jan 2025
The market experienced its best consecutive years since 1997-1998 in 2023 and 2024, despite numerous headwinds like inflation and geopolitical tensions. Factors like increasing liquidity, the AI revol
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Wednesday, 01'st Jan 2025
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2025's Five Highest Yielding Dogs of the Dow Could Explode Higher
08:08am, Wednesday, 01'st Jan 2025
The ‘Dogs of the Dow' is a well-known strategy first published in 1991 by Michael Higgins.
Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
06:55pm, Tuesday, 31'st Dec 2024
The latest trading day saw Johnson & Johnson (JNJ) settling at $144.62, representing a +0.89% change from its previous close.
J&J Trading Near 52-Week Low: Should You Sell the Stock?
11:51am, Monday, 30'th Dec 2024
Those who own the stock may stay invested for some time as J&J looks optimistic about a better performance in 2025.
5 Unbeatable Stocks I'm Eager to Buy in 2025
05:06am, Monday, 30'th Dec 2024
Investors have plenty to be thankful for in 2024. They've witnessed the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all rocket higher by a double-digit percentage and head to multiple
Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
01:32pm, Friday, 27'th Dec 2024
Johnson & Johnson JNJ, the iconic healthcare giant known for its stable dividends and defensive appeal, has entered a bearish technical pattern: the Death Cross.
JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723
08:21am, Friday, 27'th Dec 2024
Johnson & Johnson announces a global licensing deal with Kaken for the latter's eczema candidate, KP-723, to further strengthen its dermatology portfolio.
US FDA proposes standardized testing to detect asbestos in talc products
10:42am, Thursday, 26'th Dec 2024
The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to detect asbestos, a potential contaminant, according to document
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:06am, Thursday, 26'th Dec 2024
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
The Smartest Dividend Stocks to Buy With $1,000 Right Now
05:35am, Thursday, 26'th Dec 2024
If you're looking for attractive dividend-paying stocks, that's a smart move. If you're not, perhaps reconsider -- because:
